Invention Grant
![6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine](/docs/US/2017-10-24/US09796718B2/abs.jpg.600x600.jpg)
- Patent Title: 6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine
-
Application No.: US14882278Application Date: 2015-10-13
-
Publication No.: US09796718B2Publication Date: 2017-10-24
- Inventor: Scott A. Mitchell , Kevin S. Currie , Peter A. Blomgren , Jeffrey E. Kropf , Seung H. Lee , Jianjun Xu , Douglas G. Stafford , James P. Harding , Antonio J. M. Barbosa, Jr. , Zhongdong Zhao , David M. Armistead , Soumya Mitra
- Applicant: Gilead Connecticut, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Connecticut, Inc.
- Current Assignee: Gilead Connecticut, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D487/04 ; A61K31/495 ; C07D519/00 ; C07D498/04 ; C12Q1/48 ; C07D471/04 ; C07D491/107 ; G01N33/573
![6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine](/abs-image/US/2017/10/24/US09796718B2/abs.jpg.150x150.jpg)
Abstract:
Provided are imidazopyrazine compounds, particularly including 6-(benzo[d]thiazol-5-yl)-N-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine, structure below, and methods and formulations for their use in inhibiting Spleen Tyrosine Kinase in treating conditions including B-cell lymphomas or leukemias and inflammatory conditions:
Public/Granted literature
- US20160031894A1 IMIDAZOPYRAZINE SYK INHIBITORS Public/Granted day:2016-02-04
Information query
IPC分类:
